Oxidative autoaggression by phagocytes in human peritonitis

European Journal of Clinical Investigation

Volumn 27, Issue 12, 1997, Pages 1030-1037

  Billing, A G ^a   Jochum, M ^a   Frohlich D ^b   Cheronis, J C ^a   Fritz, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Departments of New Leads Chemistry and Pharmacology   (United States)

Author keywords

Chemiluminescence; Elastase; Myeloperoxidase; Peritonitis; Respiratory burst; 1 proteinase inhibitor

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 1 ANTITRYPSIN LEUKOCYTE ELASTASE COMPLEX; ALPHA 1-ANTITRYPSIN-LEUKOCYTE ELASTASE COMPLEX; LEUKOCYTE ELASTASE; OXIDIZING AGENT; PEPTIDE HYDROLASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; ENZYMOLOGY; FEMALE; HUMAN; HYDROLYSIS; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PERITONITIS; PHAGOCYTE; RESPIRATORY BURST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; HYDROLYSIS; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PEPTIDE HYDROLASES; PERITONITIS; PHAGOCYTES; RESPIRATORY BURST;

EID: 0031297871     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2280786.x     Document Type: Article

References (36)

1. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
2. Ossana PJ, Test ST, Matheson NR, Regiani S, Weiss SJ. Oxidative regulation of neutrophil elastase-ai-proteinase inhibitor interactions. J Clin Invest 1986;77:1939-51.
3. 1pproteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis. Eur Respir J 1991;4:40-9.
4. Campbell EJ, Campbell MA. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: Effects of substrate opsonization. J Cell Biol 1988;106:667-76.
5. Jochum M. Specific proteins of inflammatory cells and arproteinase inhibitor in alveolar epithelial lining fluid of polytraumatized patients: do they indicate posttraumatic lung failure? In: Sturm J, ed. Adult Respiratory Distress Syndrome. Berlin: Springer, 1991: 193-211.
6. Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung al-antitrypsin for neutrophil elastase. J Clin Invest 1991:87:1060-5.
7. Trefz G, Heck B, Schulz V, Ebert W. Functional activity of the a,proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema. Pneumologie 1989;43:446-51.
8. 1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema. Am Rev Respir Dis 1993; 147:1537-43.
9. Al-Haik N, Lewis DA, Struthers G. Neutral protease, collagenase and elastase activities in synovial fluids from arthritic patients. Agents and Actions 1984:15:436-42.
10. Chidwick K, Winyard PG, Zhang Z, Farrell AJ, Blake DR. Inactivation of the elastase inhibitory activity of a,-antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1991:50:915-16.
11. Zhang Z, Farrell AJ, Blake DR, Chidwick K, Winyard PG. Inactivation of synovial fluid a]-antitrypsin by exercise of the inflamed rheumatoid joint. FEES Lett 1993:321:274-8.
12. Chidwick K, Wichelow CE, Zhang Z el al. Relationship between ai-antitrypsin inactivation and tumor necrosis factor alpha concentration in the synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum 1994:37:1723-6.
13. Winterboum CC. Plasma antioxidants and protection against alpha1-proteinase inhibitor inactivation (letter). Am Rev Respir Dis 1986:135:767.
14. Marklund S, Holme E, Hellner L. Superoxide dismutase in extracellular fluids. Clin Chim Acta 1982; 126:41-51.
15. Dwenger A, Schweitzer G, Regel G. Bronchoalveolar lavage fluid and plasma proteins, chemiluminescence response and protein contents of polymorphonuclear leukocytes from blood and lavage fluid in traumatized patients. J Clin Chem Clin Biochem 1986; 24:73-88.
16. Alien RC. Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response by phagocytizing polymorphonuclear leukocytes. Infect Immun 1977;15:828-33.
17. Billing A, Fröhlich D, Kortmann H, Jochum M. Die Insuffizienz der intraabdominellen Infektabwehr bei der eitrigen Peritonitis. Folge einer gestörten Fremdkörperopsonierung. Klin Wochenschr I989; 67:349-56.
18. Neumann S, Gunzer G, Hennrich N, Lang H. PMN-EIastase assay: enzyme immunoassay for human polymorphonuclear elastase complexed with a,PI. J Clin Chem Clin Biochem 1984:22:693-7.
19. Neumann S, Gunzer G, Lang H, Jochum M, Fritz H. Quantitation of myeloperoxidase from human granulocytes as an inflammation marker by enzyme linked immunosorbent assay. Fres Z Anal Chem 1986:324:365.
20. Jochum M, Bittner A. Inter-alpha-trypsin inhibitor of human serum: an inhibitor of polymorphonuclear granulocyte elastase. HoppeSeyler Z Physiol Chem 1985:364:1709-15.
21. Weichselbaum TE. An accurate and rapid method for determination of proteins in small amounts of blood serum and plasma. Am J Clin Pathol 1946:16:40-4.
22. Green BG, Weston H, Ashe BM et al. PMN elastases: A comparison of the specificity of human isoenzymes and enzymes from other species towards substrates and inhibitors. Arch Biochem Biophys 1991:286:284-92.
23. Jochum M, Gippner-Steppert C, Machleidt W, Fritz H. Role of phagocyte proteinases and proteinase inhibitors in multiple organ failure (MOF). Am J Respir Crit Care Med 1994;150(Suppl.):12330.
24. Billing A, Fröhlich D, Assfalg-Machleidt I, Machleidt W, Jochum M. Proteolysis of defensive proteins in peritonitis exudate: pathobiochemical aspects and therapeutic approach. Biomed Biochim Acta 1991:50:399-402.
25. Dünn DL, Barke RA, Ewald DC, Simmons RL. Macrophages and translymphatic absorption represent the first line of host defence of the peritoneal cavity. Arch Surg 1987:122:105-10.
26. Melnicoff MJ, Horan PK, Morahan PS. Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 1989:118:178-91.
27. Assfalg-Machleidt I, Jochum M, Nast-Kolb D et al. Cathepsin B indicator for the release of lysosomal cysteine proteinases in severe trauma and inflammation. Biol Chem Hoppe-Seyler 1990; 371 (Suppl;):211-222.
28. Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparatomy for severe secondary peritonitis. Arch Surg 1995; 130:1314-20.
29. Fröhlich D, Eiber RM, Jochum M, Billing A. Perioperative pattern of peritoneal interleukin 8, tumor necrosis factor-α, and granulocyte elastase release in human secondary peritonitis. Cytokine 1997; 9:288-92.
30. Black CDV, Samuni A, Cook JA et al. Kinetics of Superoxide production by stimulated neutrophils. Arch Biochem Biophys 1991 ; 286:126-31.
31. Tono-Oka T, Matsumoto T, Ueno N, Yashiki N, Matsumoto S. Chemiluminescence of whole blood. II. Application to clinical examination of phagocytic functions of whole blood from various types of disease. Clin Immunol Immunopathol 1983;29:233-340.
32. Takahashi R, Edashige K, Sato EF, Inoue M, Matsuno T, Utsumi K. Luminol Chemiluminescence and active oxygen generation by activated neutrophils. Arch Biochem Biophys 1991;285:325-30.
33. Inthom D, Szczeponik T, Mühlbayer D, Jochum M, Redl H. Studies of the granulocyte function (chemiluminescence response) in postoperative infection. In: Schlag G, Redl H, eds. Progress in Clinical and Biological Research. Subseries: First Vienna Shock Forum. Part B: II. Monitoring and Treatment of Shock. New York: A.R. Lisslnc., 1987:51-58.
34. Johnson DA, Barren AJ, Mason RW. Cathepsin L inactivates atproteinase inhibitor by cleavage in the reactive site region. J Biol Chem 1986;261:14748-51.
35. Travis J, Salvesen G. Human plasma proteinase inhibitors. Annu Rev Biochem 1985;52:655-709.
36. Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of ori-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients. Kidney Int 1992;42:735-42.